ÂÜÀòÂÒÂ×

Mr. Papp joined DURECT in July 2022 as Chief Financial Officer and brings over 25 years of corporate finance experience to DURECT, including 15 years in the Biopharma sector. Prior to joining DURECT, he was a Managing Director of Healthcare Investment Banking at RBC Capital Markets from 2020 to 2021. Previously he was a Managing Director of Healthcare Investment Banking at Stifel, where he worked from 2010 to 2020. Prior to Stifel, he was a Vice President of Healthcare Investment Banking at Cowen, where he worked from 2007 to 2010. Mr. Papp joined Cowen from Keybanc Capital Markets, where he was an Associate in the Mergers & Acquisitions department from 2005 to 2007. Mr. Papp also worked at Rodman & Renshaw as an Associate in Investment Banking from 1997-2003. Mr. Papp graduated cum laude from Duke University with a B.S. in Economics and earned an M.B.A. from The Wharton School with a concentration in Finance.